| Title |
Frail older people with multi-morbidities in primary care: a new integrated care clinical pharmacy service
|
|---|---|
| Published in |
International Journal of Clinical Pharmacy, December 2017
|
| DOI | 10.1007/s11096-017-0566-8 |
| Pubmed ID | |
| Authors |
Lelly Oboh, Catherine Leon, Sulman Qadir, Felicity Smith, Sally-Anne Francis |
| Abstract |
Background Older people confined to their own homes due to frailty, multiple longterm conditions and/or complex needs, are known to be at risk of medicines-related problems. Whilst a health and social care team approach to supporting these patients is advocated, there is limited evidence regarding how pharmacists can best contribute. Objective To describe a new specialist pharmacy service (called the integrated care clinical pharmacist) in terms of how it works, what it achieves and its policy implications. Setting Patients' own homes in Lambeth, London, UK. Method Community matrons identified patients who were experiencing medicines related problems. These were referred to the integrated care clinical pharmacist who undertook a full medication review and recorded activities, which were independently analysed anonymously. Main outcome measure Medicines-related problems and the associated interventions. Result 143 patients were referred to the service over a 15-month period. A total of 376 medicines-related problems were identified: 28 (7%) supply issues, 107 (29%) compliance issues, 241 (64%) clinical issues. A diverse range of interventions were instigated by the pharmacist, requiring the coordination of community pharmacists, primary and secondary health and social care professionals. Conclusion This project demonstrated that including an integrated care clinical pharmacy service as part of the health and social care team that visits frail, older people in their own homes has benefits. The service operated as part of a wider inter-professional community team. The service also supported current health policy priorities in medicines optimization by identifying and addressing a wide range of medicines related problems for this vulnerable patient group. |
X Demographics
The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 12 | 36% |
| United Kingdom | 7 | 21% |
| France | 1 | 3% |
| El Salvador | 1 | 3% |
| Unknown | 12 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 55% |
| Practitioners (doctors, other healthcare professionals) | 10 | 30% |
| Scientists | 4 | 12% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 110 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 18% |
| Student > Ph. D. Student | 17 | 15% |
| Student > Master | 16 | 15% |
| Student > Bachelor | 10 | 9% |
| Lecturer > Senior Lecturer | 3 | 3% |
| Other | 11 | 10% |
| Unknown | 33 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 15% |
| Nursing and Health Professions | 15 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 14% |
| Social Sciences | 9 | 8% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Other | 14 | 13% |
| Unknown | 37 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 August 2019.
All research outputs
#1,871,950
of 25,732,188 outputs
Outputs from International Journal of Clinical Pharmacy
#57
of 1,600 outputs
Outputs of similar age
#40,738
of 447,850 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#1
of 23 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,600 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,850 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.